Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions

California Pacific Medical Center Research Institute

Status: Enrolling

Conditions: Benign Neoplasm of Intestinal Tract; Gastrointestinal Neoplasms

Study type: Observational

Funder types: Other

Identifiers

NCT01750619

2011.090

Details and patient eligibility

About

To evaluate clinical outcome for patients receiving treatment of suspected premalignant and malignant gastrointestinal lesions at Interventional Endoscopy Services. The primary outcome is curative endoscopic resection. Secondary outcomes include resection technique utilized, rates of en bloc resection and adverse event rates, including infection, bleeding, perforation and death, and one-year survival rates.

Enrollment: 4,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients age >18 years that have been referred for endoscopic treatment of GI lesions.

Exclusion criteria

• Patients for whom endoscopic treatment was not performed.

Trial design

4,000 participants in 3 patient groups

Mucosal tumors of the colon

Description:

Patients who received endoscopic treatment for noninvasive mucosal tumors of the colon.

Nonampullary tumors of the duodenum

Description:

Patients who received endoscopic treatment for noninvasive mucosal tumors of the duodenum.

Ampullary tumors

Description:

Patients who received endoscopic treatment for noninvasive ampullary tumors.